|1.||Yüksel, Meral: 4 articles (03/2010 - 09/2005)|
|2.||Farkhutdinov, U R: 4 articles (08/2007 - 01/2000)|
|3.||Yuksel, M: 3 articles (10/2015 - 03/2007)|
|4.||Scofield, Virginia L: 3 articles (02/2012 - 02/2009)|
|5.||Kuang, Xianghong: 3 articles (02/2012 - 02/2009)|
|6.||Wong, Paul K Y: 3 articles (02/2012 - 02/2009)|
|7.||Yeğen, Berrak C: 3 articles (03/2010 - 10/2006)|
|8.||Agarwal, Ashok: 2 articles (12/2015 - 11/2009)|
|9.||Sharma, Rakesh: 2 articles (12/2015 - 11/2009)|
|10.||Gabbasov, Zufar: 2 articles (01/2014 - 01/2010)|
10/01/2012 - "Live animal luminescence imaging using the chemiluminescent reporter molecule luminol showed a significant reduction in inflammation at the site where particles were injected with Dex-PA compared to the site of injection for particles within a control PA in the same animal. "
12/01/1994 - "The use of luminol-dependent chemiluminescence may prove valuable as a method to measure the earliest events in the inflammatory process, and may be an adjunct in studying the mechanisms that produce inflammation."
10/01/1993 - "The inflammation associated free radical activity was measured by the luminol-amplified chemiluminescence. "
01/01/2013 - "Intraperitoneal injection of luminol (5-amino-2,3-dihydro-1,4-phthalazinedione, sodium salt) enables detection of acute inflammation largely mediated by tissue-infiltrating neutrophils. "
10/01/1991 - "Using experimental model of uveitis, the inflammation-associated chemiluminescence was measured by luminol amplification method. "
01/01/1986 - "One week after experimental infection, PMNs from FeLV-infected cats exhibited a marked decrease in phagocytic function as determined by the luminol-dependent chemiluminescent response. "
06/01/2011 - "We have assessed the functional states of PMNs of patients with acute infections in a luminol-amplified whole blood system using the component CL approach. "
03/12/1999 - "psittaci at multiplicity of infection (MOI) of approximately 100, 10 and 1. In the presence of luminol, no detectable CL or only a weak CL response was obtained, and if present it increased with increasing MOI. "
11/01/1997 - "Oxidative burst in splenocytes in response to exposure to PMA (20 microg/ml) was significantly higher (p<.02) in infected than in control mice at two weeks post-infection using luminol-enhanced chemiluminescence. "
07/01/1992 - "We have examined the opsonic activity of sera from patients with Neisseria meningitidis (B:15:P1.16) infections against different meningococcal strains, using flow cytometry and luminol-enhanced chemiluminescence. "
|3.||Sarcoidosis (Schaumann Disease)
10/01/1988 - "Luminol chemiluminescence was similar in patients with sarcoidosis to that in controls in the first aspirate, but was significantly greater in the second and third aspirates. "
03/01/2003 - "Luminol-amplified chemiluminescence was generated by alveolar macrophages, harvested from the bronchoalveolar lavages of 16 patients with different radiological stages of non-invasive (asymptomatic) sarcoidosis. "
01/01/1987 - "No significant changes of the luminol-dependent CL of AM from sarcoidosis patients could be detected. "
02/01/1986 - "A luminol-enhanced chemiluminescence assay was used to measure light elaborated by peripheral blood polymorphonuclear leukocytes (PMNs) and by pulmonary alveolar macrophages (PAMs) from 14 healthy, normal subjects and 16 patients with sarcoidosis. "
01/01/2006 - "The functional activity of pulmonary phagocytes (alveolar macrophages and macrophages isolated from biopsy specimens) was studied in patients with active sarcoidosis and active tuberculosis, by examining the level of free radical processes in them by luminol-enhanced chemiluminescence (CL). "
12/01/2000 - "Histological examination of the kidney revealed a significant reduction in glomerular sclerosis, tubular injury, luminol protein cast accumulation, and interstitial fibrosis as well as urinary protein. "
08/01/1994 - "The reduction of Cypridina luciferin analog-dependent chemiluminescence in chronic active hepatitis and cirrhosis was more sensitive than Cypridina luciferin analog-dependent chemiluminescence; however, in hepatocellular carcinoma, luminol-dependent chemiluminescence was more reduced than luminol-dependent chemiluminescence. "
08/01/1994 - "Both Cypridina luciferin analog-dependent chemiluminescence and luminol-dependent chemiluminescence were significantly decreased in neutrophils from patients with chronic liver disease (hepatocellular carcinoma < cirrhosis < chronic active hepatitis) when they were compared with normal healthy subjects. "
07/18/2008 - "Pirfenidone (PFD) is focused on a new anti-fibrotic drug, which can minimize lung fibrosis etc. We evaluated the superoxide (O2*-) scavenging activities of PFD and the PFD-iron complex by electron spin resonance (ESR) spectroscopy, luminol-dependent chemiluminescence assay, and cytochrome c reduction assay. "
08/01/1994 - "To evaluate whether neutrophil bactericidal function, the ability to produce oxygen-derived free radicals, is altered in patients with chronic liver disease, we measured chemiluminescence amplified by a luciferin analog (Cypridina luciferin analog-dependent chemiluminescence) and luminol (luminol-dependent chemiluminescence) in response to N-formyl-Met-Lue-Phe by neutrophils from patients with chronic liver diseases due to C and/or B type hepatitis: chronic active hepatitis, cirrhosis and hepatocellular carcinoma. "
|2.||Reactive Oxygen Species (Oxygen Radicals)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|2.||Continuous Ambulatory Peritoneal Dialysis (CAPD)
|5.||Renal Dialysis (Hemodialysis)